Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schuler

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
JAMA Network Open|May 5, 2026
Workforce and Staffing at 988 Suicide & Crisis Lifeline CentersSamantha Matthews, Stephanie Brooks Holliday, Rachel Slover, et al.
BMC Medical Research Methodology|December 13, 2021
Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policiesBeth Ann Griffin, Megan S Schuler, Elizabeth A Stuart, et al.
BMC Medical Research Methodology|January 31, 2022
Correction to: Moving beyond the classic diferencein-diferences model: a simulation study comparing statistical methods for estimating efectiveness of state-level policiesBeth Ann Grifn, Megan S Schuler, Elizabeth A Stuart, et al.
Epidemiology (Cambridge, Mass.)|September 21, 2023
Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-level PoliciesBeth Ann Griffin, Megan S Schuler, Elizabeth M Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancerO S Breathnach, M S Georgiadis, B S Schuler, et al.
Journal of Lipid Research|June 4, 1998
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-IA von Eckardstein, A Chirazi, S Schuler-Lüttmann, et al.
Nature Communications|June 19, 2021
High-responsivity graphene photodetectors integrated on silicon microring resonatorsS Schuler, J E Muench, A Ruocco, et al.
Optics Express|July 28, 2016
4.3 μm quantum cascade detector in pixel configurationA Harrer, B Schwarz, S Schuler, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancerO S Breathnach, V Kasturi, F Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancerM S Georgiadis, B S Schuler, J E Brown, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
JAMA Network Open|May 5, 2026
Workforce and Staffing at 988 Suicide & Crisis Lifeline CentersSamantha Matthews, Stephanie Brooks Holliday, Rachel Slover, et al.
BMC Medical Research Methodology|December 13, 2021
Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policiesBeth Ann Griffin, Megan S Schuler, Elizabeth A Stuart, et al.
BMC Medical Research Methodology|January 31, 2022
Correction to: Moving beyond the classic diferencein-diferences model: a simulation study comparing statistical methods for estimating efectiveness of state-level policiesBeth Ann Grifn, Megan S Schuler, Elizabeth A Stuart, et al.
Epidemiology (Cambridge, Mass.)|September 21, 2023
Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-level PoliciesBeth Ann Griffin, Megan S Schuler, Elizabeth M Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancerO S Breathnach, M S Georgiadis, B S Schuler, et al.
Journal of Lipid Research|June 4, 1998
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-IA von Eckardstein, A Chirazi, S Schuler-Lüttmann, et al.
Nature Communications|June 19, 2021
High-responsivity graphene photodetectors integrated on silicon microring resonatorsS Schuler, J E Muench, A Ruocco, et al.
Optics Express|July 28, 2016
4.3 μm quantum cascade detector in pixel configurationA Harrer, B Schwarz, S Schuler, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancerO S Breathnach, V Kasturi, F Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancerM S Georgiadis, B S Schuler, J E Brown, et al.
Pageof 20